Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

被引:35
作者
Liu, ML
Taketani, T
Li, RS
Takita, J
Taki, T
Yang, HW
Kawaguchi, H
Ida, K
Matsuo, Y
Hayashi, Y
机构
[1] Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan
[2] Beijing Union Med Coll Hosp, Dept Hematol, Beijing 100730, Peoples R China
[3] Hayashibara Biochem Labs Inc, Fujisaki Cell Ctr, Okayama 7028006, Japan
关键词
acute lymphoblastic leukemia; p73; gene; p53; methylation;
D O I
10.1016/S0145-2126(00)00148-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of the p73 gene and the methylation status was examined in 61 acute lymphoblastic leukemia (ALL) cell lines and lymphocytes from seven healthy individuals. p73 mRNA was not expressed in 19 (31.1%) of 61 ALL cell lines, including 11 (31.4%) of 35 B-precursor ALL cell lines, 2 (16.7%) of 12 B-ALL/Burkitt lymphoma (BL) cell lines (totally 27.7% of B-lineage cell lines). 6 (42.9%) of 14 T-ALL cell lines, and expressed in all of normal lymphocytes, by reverse transcriptase-polymerase chain reaction (RT-PCR). Restriction-enzyme related PCR (REP) and methylation-specific PCR (MSP) revealed that the cell lines lacking p73 mRNA expression were hypermethylated. In contrast, normal lymphocytes and most cell lines that expressed detectable p73 mRNA were not hypermethylated with the exception of five cell lines. Furthermore, bisulfite genomic sequencing confirmed the results obtained by REP and MSP. Our results suggest that p73 inactivation may be involved in the pathogenesis of both T- and B-ALLs, and that hypermethylation is the predominant mechanism of inactivation of the p73 gene in ALL. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:441 / 447
页数:7
相关论文
共 38 条
  • [1] CPG-RICH ISLANDS AND THE FUNCTION OF DNA METHYLATION
    BIRD, AP
    [J]. NATURE, 1986, 321 (6067) : 209 - 213
  • [2] p15INK4B CPG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing
    Cameron, EE
    Baylin, SB
    Herman, JG
    [J]. BLOOD, 1999, 94 (07) : 2445 - 2451
  • [3] Chi SG, 1999, CANCER RES, V59, P2791
  • [4] Corn PG, 1999, CANCER RES, V59, P3352
  • [5] Two new p73 splice variants, γ and δ, with different transcriptional activity
    De Laurenzi, V
    Costanzo, A
    Barcaroli, D
    Terrinoni, A
    Falco, M
    Annicchiarico-Petruzzeli, M
    Levrero, M
    Melino, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) : 1763 - 1768
  • [6] PARENTAL-ORIGIN-SPECIFIC EPIGENETIC MODIFICATION OF THE MOUSE H19 GENE
    FERGUSONSMITH, AC
    SASAKI, H
    CATTANACH, BM
    SURANI, MA
    [J]. NATURE, 1993, 362 (6422) : 751 - 755
  • [7] Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
    Guo, SX
    Taki, T
    Ohnishi, H
    Piao, HY
    Tabuchi, K
    Bessho, F
    Hanada, R
    Yanagisawa, M
    Hayashi, Y
    [J]. LEUKEMIA RESEARCH, 2000, 24 (01) : 39 - 46
  • [8] SILENCING OF THE VHL TUMOR-SUPPRESSOR GENE BY DNA METHYLATION IN RENAL-CARCINOMA
    HERMAN, JG
    LATIF, F
    WENG, YK
    LERMAN, MI
    ZBAR, B
    LIU, S
    SAMID, D
    DUAN, DSR
    GNARRA, JR
    LINEHAN, WM
    BAYLIN, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 9700 - 9704
  • [9] Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
    Herman, JG
    Graff, JR
    Myohanen, S
    Nelkin, BD
    Baylin, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9821 - 9826
  • [10] p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent
    Ichimiya, S
    Nimura, Y
    Kageyama, H
    Takada, N
    Sunahara, M
    Shishikura, T
    Nakamura, Y
    Sakiyama, S
    Seki, N
    Ohira, M
    Kaneko, Y
    McKeon, F
    Caput, D
    Nakagawara, A
    [J]. ONCOGENE, 1999, 18 (04) : 1061 - 1066